Capsule vs Moderna

Side-by-side comparison of AI visibility scores, market position, and capabilities

Moderna leads in AI visibility (90 vs 60)
Capsule logo

Capsule

ChallengerHealthcare

Online Pharmacy

Tech-enabled NYC pharmacy with same-day prescription delivery; proactive pharmacist service and seamless insurance management for consumers prioritizing convenience.

AI VisibilityBeta
Overall Score
B60
Category Rank
#125 of 596
AI Consensus
75%
Trend
stable
Per Platform
ChatGPT
66
Perplexity
63
Gemini
56

About

Capsule is a tech-enabled online pharmacy providing prescription delivery in New York City, with a focus on superior customer experience — free same-day delivery, a clean app interface, automatic refill management, and proactive pharmacist communication that traditional chain pharmacies cannot match. Founded in 2016 and headquartered in New York City, Capsule raised over $300 million in funding from investors including Thrive Capital and has built a model that treats the pharmacy as a healthcare touchpoint rather than a retail transaction.

Full profile
Moderna logo

Moderna

LeaderHealthcare Tech

Enterprise

mRNA pioneer with $3.2B FY2024 revenue (down from $18.4B 2022 COVID peak); mRESVIA RSV vaccine approved 2024; personalized cancer vaccine with Merck shows 44% recurrence reduction in melanoma.

AI VisibilityBeta
Overall Score
A90
Category Rank
#2 of 596
AI Consensus
83%
Trend
stable
Per Platform
ChatGPT
92
Perplexity
93
Gemini
89

About

Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stéphane Bancel, and others in Cambridge, Massachusetts, where it is headquartered and trades on Nasdaq (MRNA). The company achieved extraordinary commercial success with Spikevax, its COVID-19 mRNA vaccine developed in partnership with the U.S. government in 2020—generating $18.4 billion in COVID vaccine revenues in 2022 at peak—before experiencing a severe revenue decline as global COVID booster demand normalized. For FY2024, Moderna generated approximately $3.2 billion in revenues, with Spikevax and the reformulated XBB.1.5-targeting COVID vaccine contributing the majority, while the company's significant R&D investment pipeline consumed most operating cash flows.

Full profile

AI Visibility Head-to-Head

60
Overall Score
90
#125
Category Rank
#2
75
AI Consensus
83
stable
Trend
stable
66
ChatGPT
92
63
Perplexity
93
56
Gemini
89
59
Claude
96
58
Grok
95

Key Details

Category
Online Pharmacy
Enterprise
Tier
Challenger
Leader
Entity Type
brand
company

Capabilities & Ecosystem

Capabilities

Only Capsule
Online Pharmacy

Integrations

Only Moderna
Moderna is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.